Audited Financial Results for the 4th quarter and financial year ended March 31, 2025 published in Newspaper.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Resonance Specialties Limited published its audited financial results for Q4 FY25 and the full year ended March 31, 2025 in Business Standard (all editions) and Nav Shakti (Marathi) on May 20, 2025, after Board approval on May 19, 2025. Total income from operations rose about 41% year-on-year to Rs 7,780.66 lakhs in FY25, up from Rs 5,530.09 lakhs in FY24, with Q4 income at Rs 2,420.17 lakhs versus Rs 1,823.82 lakhs a year earlier. Net profit after tax more than doubled to Rs 656.62 lakhs in FY25 (from Rs 296.84 lakhs in FY24), while Q4 PAT jumped to Rs 305.75 lakhs from Rs 111.55 lakhs. Basic and diluted EPS for FY25 rose to Rs 5.65 from Rs 2.56, and reserves stood at Rs 4,881.14 lakhs as on March 31, 2025. The Board has recommended a dividend of Rs 1 per share (10%) on the face value of Rs 10 for FY25, and the India segment revenue surged about 80% YoY to Rs 4,369.58 lakhs.
This is a strong set of audited full-year numbers, with profits more than doubling and a healthy 10% dividend, which is positive for shareholders and likely to be viewed favourably by the market. The disclosure itself is a routine newspaper publication under SEBI rules, but the underlying results are materially better than the previous year.